Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 416
Recruiting: 234
Ph III recruiting: 21
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04313075	A Compassionate Use Study of Leronlimab in Breast Cancer	no longer available	—	—	CytoDyn, Inc.INDUSTRY	0	Jul 15, 2025	clinicaltrials
NCT03123211	Expanded Access to Veliparib	no longer available	—	—	AbbVieINDUSTRY	0	May 24, 2022	clinicaltrials
NCT02985658